As expected, the blood level of CD19+CD1d+ of RA patients was significantly lower compared to those of healthy controls (P = 0.0001); notably, their blood levels increased significantly after treatment with abatacept (Supplementary Fig. 3A; P = 0.0021). Here, CD1D is linked to rheumatoid arthritis.